PetCaseFinder

Peer-reviewed veterinary case report

N-Acetyl-L-Cysteine for reducing inflammation after surgery in rats?

By Parpoudi S et al.·2025·Surgical Breast Oncology Department·View original on Europe PMC

PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →

Original publication title: Effect of N-Acetyl-L-Cysteine (NAC) on Inflammation After Intraperitoneal Mesh Placement in an <i>Escherichia coli</i> Septic Rat Model: A Randomized Experimental Study.

Species:
rodent

Plain-English summary

In a study involving rats, researchers looked at whether a substance called N-acetyl-L-cysteine (NAC) could help reduce inflammation after placing a mesh in the abdomen of rats infected with E. coli bacteria. The rats that received NAC showed significantly less adhesion formation and better tissue health compared to those that did not receive NAC. Additionally, the levels of certain inflammatory markers in the blood were lower in the NAC-treated group. Overall, NAC appeared to help reduce inflammation and improve healing in this model of infection. This suggests that NAC could be a helpful addition to antibiotic treatment in similar situations, though more research is needed to determine the best way to use it.

Abstract

<b>Background/Objectives</b>: The safety of intraperitoneal mesh placement in contaminated fields remains controversial because of the increased risk of inflammation and adhesion formation. N-acetyl-L-cysteine (NAC) has antioxidant, pro-fibrinolytic and antibiofilm actions that could attenuate this response. The aim of this study is to determine whether NAC reduces mesh-related inflammation in a septic model created by intraperitoneal <i>Escherichia coli</i> (<i>E.coli</i>) inoculation. The primary comparison was prospectively defined between <i>E. coli</i>-inoculated animals treated with NAC (D) and those without NAC (B). Groups without <i>E. coli</i> (A,C,E) are presented for context and were compared previously. <b>Methods</b>: In this randomized, double-blind experimental model (five groups, <i>n</i> = 20 per group), all rats underwent midline laparotomy with intraperitoneal placement of a composite mesh, followed by standardized ciprofloxacin administration. The septic groups received intraperitoneal <i>E. coli</i>, while the NAC-treated groups additionally received intraperitoneal NAC (150 mg/kg). Serum levels of IL-1α, IL-6, and TNF-α were measured on postoperative days 7, 14, and 21. On day 21, adhesions were graded using the Modified Diamond system, histology (inflammatory infiltration, fibrosis, neovascularization) was scored, and mesh cultures were obtained. Cytokine data were analyzed with repeated-measures ANOVA, while categorical or ordinal outcomes were assessed using χ<sup>2</sup> or Fisher's exact tests with Bonferroni-adjusted pairwise comparisons. <b>Results</b>: <i>E. coli</i> inoculation significantly increased adhesion burden and worsened histologic scores compared with controls (both <i>p</i> < 0.001). NAC administration in the septic model significantly reduced adhesions and improved all histologic domains relative to <i>E. coli</i> alone (all <i>p</i> ≤ 0.003), with values comparable to controls (non-significant across domains). For cytokines, there was a significant overall group effect for IL-1α, IL-6, and TNF-α (all <i>p</i> < 0.001), without a main effect of time or time × group interaction. Pairwise contrasts showed lower IL-1α (<i>p</i> = 0.024), IL-6 (<i>p</i> < 0.001), and TNF-α (<i>p</i> < 0.001) levels in group D versus B, and lower IL-6 and TNF-α in group D versus A (both <i>p</i> < 0.001). Mesh culture positivity rate was higher in group B than A (<i>p</i> < 0.001) and showed a non-significant reduction in group D versus B (<i>p</i> = 0.10). No perioperative deaths occurred. <b>Conclusions</b>: NAC attenuated septic, mesh-associated inflammation-normalizing adhesions and histology and reducing IL-6 and TNF-α- supporting its role as a host-directed adjunct alongside antibiotics. Further translational studies are warranted to define the optimal dose, timing, and clinical indications.

Find similar cases for your pet

PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.

Search related cases →

Original publication on Europe PMC: https://europepmc.org/article/MED/41440550